Ambit Biosciences , a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, today announced that it will report third quarter 2013 operational results after closing of the NASDAQ Global Market on Thursday, November 7, 2013.
http://www.freshnews.com/news/865166/ambit-biosciences-announce-third-quarter-2013-financial-and-operating-results-and-confe
http://www.freshnews.com/news/865166/ambit-biosciences-announce-third-quarter-2013-financial-and-operating-results-and-confe
No comments:
Post a Comment